Multiparametric MRI
9
2
4
2
Key Insights
Highlights
Success Rate
67% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 72/100
11.1%
1 terminated out of 9 trials
66.7%
-19.8% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (9)
Early Magnetic Resonance Imaging Response of the Dominant Intraprostatic Lesion After Online Adaptive Stereotactic Body Radiotherapy for Localized Prostate Cancer and Correlation With Prostate Specific Antigen Response
Reproducibility of Multiparametric Renal Magnetic Resonance Imaging on 1.5T MRI Scanners
The Added-value of PSMA PET in Detecting Clinically Significant Prostate Cancer Lesions in Patients Undergoing MRI-targeted Biopsy. (PANDORA)
Deep Learning Super Resolution Reconstruction for Fast and Motion Robust T2-weighted Prostate MRI
Use of Multiparametric MRI in the Management of Head and Neck Cancer: a Retrospective Analysis
Use of Multiparametric MRI in the Management of Head and Neck Cancer: a Prospective Analysis
Clinical Utility of VI-RADS in Diagnosis of MIBC
Radiomics of Mp-MRI Assessing NAC Outcome in Breast Cancer
MRI-Based Active Surveillance to Avoid the Risks of Serial Biopsies in Men With Low-Risk Prostate Ca